Tom Manley

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

Andrew S. Levey, Ron T. Gansevoort, Josef Coresh et al. · American Journal of Kidney Diseases · 2019 · 529 citations · Full text

Glomerulonephritis, Hemodialysis, Renal Function +10

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation

Katherine R. Tuttle, Frank C. Brosius, Matthew A. Cavender et al. · American Journal of Kidney Diseases · 2020 · 120 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +12

Experience with transplantation of human cryopreserved ovarian tissue to a sub-peritoneal abdominal site

Debra A. Gook, Lyndon Hale, Alex Polyakov et al. · Human Reproduction · 2021 · 19 citations

Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists

Joshua J. Neumiller, Jay H. Shubrook, Tom Manley et al. · American Journal of Health-System Pharmacy · 2021 · 10 citations

Diabetes Management, Renal Function, Renal Disease +9